Report : A-Z CDF items in Formulary 12/04/2021 01:11:35

[Back]

Section Status CDF Name 08.01.05 Formulary Abemaciclib Verzenios® 08.01.05 Formulary Acalabrutinib Calquence® 08.01.05 Formulary Atezolizumab Tecentriq® 08.01.05 Formulary Avelumab Bavencio® 08.01.05 Restricted Use Axicabtagene ciloleucel YESCARTA® 08.01.01 Formulary Bendamustine Levact® 08.01.05 Formulary Bevacizumab Avastin® 08.01.05 Formulary Binimetinib Mektovi® 08.01.05 Formulary Bortezomib Velcade® 08.01 Formulary Cabozantinib Cometriq® 08.01.05 Formulary Cemiplimab Libtayo® 08.01.03 Formulary Clofarabine Evoltra® 08.01.05 Formulary Crizotinib Xalkori® 08.01.05 Formulary Daratumumab DARZALEX® 08.01.02 Formulary Doxorubicin Hydrochloride Caelyx® 08.01.05 Formulary Durvalumab Imfinzi® 08.01.05 Formulary Encorafenib Braftovi® 08.01.05 Formulary Entrectinib Rozlytrek® 08.03.04.01 Formulary Fulvestrant Faslodex® 08.01.05 Formulary Ibrutinib Imbruvica® 08.01.05 Formulary Ipilimumab YERVOY ® 08.01.05 Formulary Isatuximab Sarclisa® 08.01.05 Formulary Ixazomib Ninlaro® 08.01.05 Restricted Use Larotrectinib Vitrakvi® 08.02.04 Formulary Lenalidomide Revlimid® 08.01.05 Formulary Lutetium (177Lu) oxodotreotide Lutathera® 08.01.03 Formulary Nelarabine Atriance® 08.01.05 Formulary Niraparib Zejula® 08.01.05 Formulary Nivolumab Opdivo® 08.01.05 Formulary Olaparib Lynparza® 08.01.05 Non Formulary Olaratumab Lartruvo® 08.01.05 Formulary Palbociclib IBRANCE® 08.01.05 Formulary Pembrolizumab Keytruda® 08.01.05 Formulary Pemigatinib Pemazyre® 08.01.05 Formulary Ribociclib Kisqali® 08.01.05 Formulary Rucaparib Rubraca® 08.01.05 Formulary Sorafenib Nexavar® 08.01.05 Restricted Use Tisagenlecleucel Kymriah® 08.01.05 Formulary Trametinib Mekinist® 08.01.05 Non Formulary Vandetanib Caprelsa® 08.01.05 Formulary Venetoclax Venclyxto®

Dorset